Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans

Research output: Contribution to journalReviewResearchpeer-review

Standard

Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans. / Kuempel, Eileen D.; Jaurand, Marie-Claude; Møller, Peter; Morimoto, Yasuo; Kobayashi, Norihiro; Pinkerton, Kent E.; Sargent, Linda M.; Vermeulen, Roel C. H.; Fubini, Bice; Kane, Agnes B.

In: Critical Reviews in Toxicology, Vol. 47, No. 1, 2017, p. 1-58.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Kuempel, ED, Jaurand, M-C, Møller, P, Morimoto, Y, Kobayashi, N, Pinkerton, KE, Sargent, LM, Vermeulen, RCH, Fubini, B & Kane, AB 2017, 'Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans', Critical Reviews in Toxicology, vol. 47, no. 1, pp. 1-58. https://doi.org/10.1080/10408444.2016.1206061

APA

Kuempel, E. D., Jaurand, M-C., Møller, P., Morimoto, Y., Kobayashi, N., Pinkerton, K. E., ... Kane, A. B. (2017). Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans. Critical Reviews in Toxicology, 47(1), 1-58. https://doi.org/10.1080/10408444.2016.1206061

Vancouver

Kuempel ED, Jaurand M-C, Møller P, Morimoto Y, Kobayashi N, Pinkerton KE et al. Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans. Critical Reviews in Toxicology. 2017;47(1):1-58. https://doi.org/10.1080/10408444.2016.1206061

Author

Kuempel, Eileen D. ; Jaurand, Marie-Claude ; Møller, Peter ; Morimoto, Yasuo ; Kobayashi, Norihiro ; Pinkerton, Kent E. ; Sargent, Linda M. ; Vermeulen, Roel C. H. ; Fubini, Bice ; Kane, Agnes B. / Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans. In: Critical Reviews in Toxicology. 2017 ; Vol. 47, No. 1. pp. 1-58.

Bibtex

@article{8171def9af4645cdbc523da252f5aa9b,
title = "Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans",
abstract = "In an evaluation of carbon nanotubes (CNTs) for the IARC Monograph 111, the Mechanisms Subgroup was tasked with assessing the strength of evidence on the potential carcinogenicity of CNTs in humans. The mechanistic evidence was considered to be not strong enough to alter the evaluations based on the animal data. In this paper, we provide an extended, in-depth examination of the in vivo and in vitro experimental studies according to current hypotheses on the carcinogenicity of inhaled particles and fibers. We cite additional studies of CNTs that were not available at the time of the IARC meeting in October 2014, and extend our evaluation to include carbon nanofibers (CNFs). Finally, we identify key data gaps and suggest research needs to reduce uncertainty. The focus of this review is on the cancer risk to workers exposed to airborne CNT or CNF during the production and use of these materials. The findings of this review, in general, affirm those of the original evaluation on the inadequate or limited evidence of carcinogenicity for most types of CNTs and CNFs at this time, and possible carcinogenicity of one type of CNT (MWCNT-7). The key evidence gaps to be filled by research include: investigation of possible associations between in vitro and early-stage in vivo events that may be predictive of lung cancer or mesothelioma, and systematic analysis of dose–response relationships across materials, including evaluation of the influence of physico-chemical properties and experimental factors on the observation of nonmalignant and malignant endpoints.",
keywords = "Cancer mechanisms, carbon nanofibers, carbon nanotubes, cell proliferation, fibrosis, genotoxicity, inflammation, lung cancer, mesothelioma, particle retention, pulmonary, translocation",
author = "Kuempel, {Eileen D.} and Marie-Claude Jaurand and Peter M{\o}ller and Yasuo Morimoto and Norihiro Kobayashi and Pinkerton, {Kent E.} and Sargent, {Linda M.} and Vermeulen, {Roel C. H.} and Bice Fubini and Kane, {Agnes B.}",
year = "2017",
doi = "10.1080/10408444.2016.1206061",
language = "English",
volume = "47",
pages = "1--58",
journal = "Critical Reviews in Toxicology",
issn = "1040-8444",
publisher = "Taylor & Francis",
number = "1",

}

RIS

TY - JOUR

T1 - Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humans

AU - Kuempel, Eileen D.

AU - Jaurand, Marie-Claude

AU - Møller, Peter

AU - Morimoto, Yasuo

AU - Kobayashi, Norihiro

AU - Pinkerton, Kent E.

AU - Sargent, Linda M.

AU - Vermeulen, Roel C. H.

AU - Fubini, Bice

AU - Kane, Agnes B.

PY - 2017

Y1 - 2017

N2 - In an evaluation of carbon nanotubes (CNTs) for the IARC Monograph 111, the Mechanisms Subgroup was tasked with assessing the strength of evidence on the potential carcinogenicity of CNTs in humans. The mechanistic evidence was considered to be not strong enough to alter the evaluations based on the animal data. In this paper, we provide an extended, in-depth examination of the in vivo and in vitro experimental studies according to current hypotheses on the carcinogenicity of inhaled particles and fibers. We cite additional studies of CNTs that were not available at the time of the IARC meeting in October 2014, and extend our evaluation to include carbon nanofibers (CNFs). Finally, we identify key data gaps and suggest research needs to reduce uncertainty. The focus of this review is on the cancer risk to workers exposed to airborne CNT or CNF during the production and use of these materials. The findings of this review, in general, affirm those of the original evaluation on the inadequate or limited evidence of carcinogenicity for most types of CNTs and CNFs at this time, and possible carcinogenicity of one type of CNT (MWCNT-7). The key evidence gaps to be filled by research include: investigation of possible associations between in vitro and early-stage in vivo events that may be predictive of lung cancer or mesothelioma, and systematic analysis of dose–response relationships across materials, including evaluation of the influence of physico-chemical properties and experimental factors on the observation of nonmalignant and malignant endpoints.

AB - In an evaluation of carbon nanotubes (CNTs) for the IARC Monograph 111, the Mechanisms Subgroup was tasked with assessing the strength of evidence on the potential carcinogenicity of CNTs in humans. The mechanistic evidence was considered to be not strong enough to alter the evaluations based on the animal data. In this paper, we provide an extended, in-depth examination of the in vivo and in vitro experimental studies according to current hypotheses on the carcinogenicity of inhaled particles and fibers. We cite additional studies of CNTs that were not available at the time of the IARC meeting in October 2014, and extend our evaluation to include carbon nanofibers (CNFs). Finally, we identify key data gaps and suggest research needs to reduce uncertainty. The focus of this review is on the cancer risk to workers exposed to airborne CNT or CNF during the production and use of these materials. The findings of this review, in general, affirm those of the original evaluation on the inadequate or limited evidence of carcinogenicity for most types of CNTs and CNFs at this time, and possible carcinogenicity of one type of CNT (MWCNT-7). The key evidence gaps to be filled by research include: investigation of possible associations between in vitro and early-stage in vivo events that may be predictive of lung cancer or mesothelioma, and systematic analysis of dose–response relationships across materials, including evaluation of the influence of physico-chemical properties and experimental factors on the observation of nonmalignant and malignant endpoints.

KW - Cancer mechanisms

KW - carbon nanofibers

KW - carbon nanotubes

KW - cell proliferation

KW - fibrosis

KW - genotoxicity

KW - inflammation

KW - lung cancer

KW - mesothelioma

KW - particle retention

KW - pulmonary

KW - translocation

U2 - 10.1080/10408444.2016.1206061

DO - 10.1080/10408444.2016.1206061

M3 - Review

C2 - 27537422

VL - 47

SP - 1

EP - 58

JO - Critical Reviews in Toxicology

JF - Critical Reviews in Toxicology

SN - 1040-8444

IS - 1

ER -

ID: 174471072